Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of $1.76 by 48.63 percent. This is a 16.08 percent decrease over earnings of $3.11 per share from the same period last year. The company reported quarterly sales of $651.600 million which beat the analyst consensus estimate of $615.110 million by 5.93 percent. This is a 2.06 percent increase over sales of $638.476 million the same period last year.